Bibliographies thématiques / Cardiae diseases / Articles de revues

Articles de revues sur le sujet « Cardiae diseases »

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Cardiae diseases.
Auteur : Grafiati
Publié le 18 mai 2024

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Cardiae diseases ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Subramaniyan, Mahadevan, Vijayakumar Subramaniyan et Arulmozhi Praveenkumar. « Phytochemical Analysis and Antimicrobial Activities of Atalantia monophylla (L) Correa and Atalantia racemosa Wight and Arn ». Current Bioactive Compounds 15, no 4 (4 juillet 2019) : 427–36. http://dx.doi.org/10.2174/1573407214666180521105026.

Texte intégral
Résumé :
Background: Infectious diseases are major leading cause of death in all parts of the world, because of the appearance of new multi drug resistant microbes. Therefore, the discovery of potential drug for effective treatment will help the slaughter of the microbes. The aim of the present study is to evaluate the presence of photochemical and antimicrobial activities of various crude extracts of leaves, fruits and root bark of Atalantia monophylla and Atalantia racemosa against human pathogens by using well diffusion method. Methods: Antimicrobial properties of the various extracts of Atalantia monophylla and Atalantia racemosa were studied against some human pathogenic microbes such as Gram-positive Bacteria, (Bacillus subtilis, Bacillus cereus, Staphylococcus aureus) Gram-negative Bacteria (Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli) and human opportunistic fungal pathogens (Candida albicans and Aspergillus niger). All the extracts were comparable with standard drugs (Ciprofloxacin, Gentamicin, Nystatin. and Amphotericin B). Minimum inhibitory concentration (MIC), minimum bactericidal /fungicidal concentration (MBC/MFC) values were determined through a microdilution method. The phytochemical analysis of these plant extracts were carried out using standard mthods. Results: Methanolic leaf extract of A. monophylla has showed excellent antimicrobial activity against S. aureus (40mm). As well, the A. racemosa methanolic leaf extract shows notable inhibitory activity against S. aureus (38mm). At the same time, the least inhibition was observed in aqueous extract of A. monophylla against E.coli (9mm). The MIC ranged from 0.78 µg/mL to 50 µg/mL and MBC/MFC 1.56 to 50 µg/mL were recorded. Phytochemical analysis of alkaloids, steroids, saponins, flavonoids, tannins, terpenoids, phenolics and cardiae glycoside were recorded in various extracts of A. monophylla and A. racemosa respectively. Flavonoids, phenolics and cardiac glycoside were present only in methonalic leaf extract of A. monophylla. Conclusion: The result of this study concluded that methanolic leaf extract has possessed novel compounds with significant antimicrobial properties. Hence, we recommend this plant for further studies on the isolation and characterization of that lead antimicrobial potential molecule.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Navarro-Lopez, Francisco. « Cardiac Diseases ». Clinical Science 90, no 3 (1 mars 1996) : 156–58. http://dx.doi.org/10.1042/cs0900156.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Sharma, Richa, et Shailendra Narayan Singh. « An Efficient Hybrid Classifier for Prognosing Cardiac Disease ». Webology 19, no 1 (20 janvier 2022) : 5028–46. http://dx.doi.org/10.14704/web/v19i1/web19338.

Texte intégral
Résumé :
Machine learning (ML) is a powerful tool which empowers the practitioners for predictions upon any existing or real- time data. Here, the Machine first understands the valuable patterns from the dataset and then uses that information to make predictions on the unknown data. Further, classification is the commonly used machine learning approach (ML-Approach) to make such predictions. The objective of this work aims to design and development of an ensemble classifier for prognosing cardiovascular disease (heart disease). The developed classifier integrates Support Vector Machine (SVM), K–Nearest Neighbor (K-NN), and Weighted K-NN. The applicability of ensemble classifier is evaluated on the Cleveland Heart disease dataset. Some other classifiers such as Logistic Regression (LR), Sequential Minimal Optimization (SMO), K-NN+Weighted K-NN are also implemented on the same dataset to make the performance analysis. The results of this study depict the significant improvement in the Sensitivity and Specificity parameter.
Styles APA, Harvard, Vancouver, ISO, etc.
4

Cocco, Giuseppe. « Geriatric Cardiac Diseases ». OBM Geriatrics 4, no 2 (1 avril 2020) : 1–3. http://dx.doi.org/10.21926/obm.geriatr.2002112.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Ekpe EE et Anyanwu CH. « Accuracy of trans-thoracic echocardiography as a pericardial diseases diagnostic tool ». Ibom Medical Journal 1, no 1 (1 août 2006) : 1–4. http://dx.doi.org/10.61386/imj.v1i1.1.

Texte intégral
Résumé :
SummaryA prospective comparison of pre-operative trans-thoracic echocardiographic findings with intra-operative findings of 17 patients operated on for pericardial diseases showed excellent correlation for pericardial calcification and adhesion, and for myo-cardial atrophy, and good correlation for pericardial thickening, constriction and effusion respectively. This excellent correlation identified high-risk cases that should have heart-lung machine kept on the stand-by during operation of peri-cardiectomy in event of iatrogenic cardiac chamber laceration. KeywordsPre-operative transthoracic echocardiography, pericarditis, correlation.
Styles APA, Harvard, Vancouver, ISO, etc.
6

Sen, Sujoita, Logan Hallee et Chi Keung Lam. « The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases ». Journal of Personalized Medicine 11, no 12 (4 décembre 2021) : 1294. http://dx.doi.org/10.3390/jpm11121294.

Texte intégral
Résumé :
Heart diseases are some of the most common and pressing threats to human health worldwide. The American Heart Association and the National Institute of Health jointly work to annually update data on cardiac diseases. In 2018, 126.9 million Americans were reported as having some form of cardiac disorder, with an estimated direct and indirect total cost of USD 363.4 billion. This necessitates developing therapeutic interventions for heart diseases to improve human life expectancy and economic relief. In this review, we look into gamma-secretase as a potential therapeutic target for cardiac diseases. Gamma-secretase, an aspartyl protease enzyme, is responsible for the cleavage and activation of a number of substrates that are relevant to normal cardiac development and function as found in mutation studies. Some of these substrates are involved in downstream signaling processes and crosstalk with pathways relevant to heart diseases. Most of the substrates and signaling events we explored were found to be potentially beneficial to maintain cardiac function in diseased conditions. This review presents an updated overview of the current knowledge on gamma-secretase processing of cardiac-relevant substrates and seeks to understand if the modulation of gamma-secretase activity would be beneficial to combat cardiac diseases.
Styles APA, Harvard, Vancouver, ISO, etc.
7

Salgiya, Dr Nirali. « Correlation of Serum Cardiac Troponin-T with Chronic Kidney Disease ». Journal of Medical Science And clinical Research 05, no 06 (30 juin 2017) : 24178–86. http://dx.doi.org/10.18535/jmscr/v5i6.222.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

C, Devadawson. « Fish Consumption and Cardio Vascular Diseases in Sri Lanka ». International Journal of Science and Research (IJSR) 13, no 3 (5 mars 2024) : 1838–49. http://dx.doi.org/10.21275/sr24327151256.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Romakina, V. V., I. V. Zhirov, S. N. Nasonova, A. V. Zaseeva, A. G. Kochetov, O. V. Liang et S. N. Tereshchenko. « MicroRNAs as Biomarkers of Cardiovascular Diseases ». Kardiologiia 17, no 1 (2018) : 66–71. http://dx.doi.org/10.18087/cardio.2018.1.10083.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Colpaert, Robin M. W., et Martina Calore. « MicroRNAs in Cardiac Diseases ». Cells 8, no 7 (18 juillet 2019) : 737. http://dx.doi.org/10.3390/cells8070737.

Texte intégral
Résumé :
Since their discovery 20 years ago, microRNAs have been related to posttranscriptional regulation of gene expression in major cardiac physiological and pathological processes. We know now that cardiac muscle phenotypes are tightly regulated by multiple noncoding RNA species to maintain cardiac homeostasis. Upon stress or various pathological conditions, this class of non-coding RNAs has been found to modulate different cardiac pathological conditions, such as contractility, arrhythmia, myocardial infarction, hypertrophy, and inherited cardiomyopathies. This review summarizes and updates microRNAs playing a role in the different processes underlying the pathogenic phenotypes of cardiac muscle and highlights their potential role as disease biomarkers and therapeutic targets.
Styles APA, Harvard, Vancouver, ISO, etc.
11

HOQUE, M., A. C. SAXENA, REETU, M. B. GUGJOO et D. BODH. « Cardiac diseases in dogs ». Indian Journal of Animal Health 58, no 01 (1 juin 2019) : 01. http://dx.doi.org/10.36062/ijah.58.1.2019.01-20.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
12

Latif, Lubna, et Usman Javed Iqbal. « PREVALENCE OF CARDIAC DISEASES ». Professional Medical Journal 22, no 11 (10 novembre 2015) : 1443–48. http://dx.doi.org/10.29309/tpmj/2015.22.11.922.

Texte intégral
Résumé :
Objectives: The objective of this study was to find the prevalence of cardiacdisease among pregnant females and its impact on feto-maternal outcome. Study Design:Descriptive case series. Setting: Cardiology department Gulab Devi Chest Hospital LahoreDuration: April 2013 to April 2014. Patients & Methods: All pregnant females with cardiacdisease at any gestation with booked or un-booked statutes were included in this study. Patientswere admitted for thorough evaluation and investigations. Labor was monitored intensively. Dataregarding maternal outcomes were noted down on pre-formed questionnaire. Intra partum andpostpartum details were also noted down along with fetal outcome. The results were analyzedusing SPSS version 16.0.. Results: The total number of females presented with cardiac diseasewas 2650, out of which only 35 women were reported as pregnant. The duration of pregnancyat the time of presentation was as follows: 05 (14.2%) females presented in first trimester, 20(57.1%) in second trimester, 08 (22.8%) in third trimester and 02 (5.7%) patients presented inpostpartum period. There were 08 (22.8%) patients who had preterm labor. In terms of fetaloutcome 04 babies had birth weight of less than 1.5 kg, 12 had 1.5-2.0 kg, 15 were in rangeof 2-2.5 kg and 04 were more than 2.5 kg. 27 (77.1%) were term and 08 (22.8%) were pretermbabies. Cleft lip and atrial septal defect were the only two identified congenital anomalies.Conclusion: The overall prevalence of cardiac diseases during pregnancy was found to be1.3% in this study. Most common affected age group was of 20-25 years. Most common cardiacdisease found in our patient was mitral stenosis. 02 pregnancies ended in intrauterine fetaldeath. 08 babies were born preterm. Cleft lip and atrial septal defect were the only two identifiedcongenital anomalies in newborn delivered by our pregnant patients. Every effort should madeto create awareness regarding pre-pregnancy counseling, so that associated fetal and maternalmorbidity can be reduced.
Styles APA, Harvard, Vancouver, ISO, etc.
13

Kathuria, Sanjeev, Abhimanyu Uppal, Vimal Mehta et Anunyay Gupta. « Cardiac Diseases and Obesity ». Journal of Postgraduate Medicine, Education and Research 55, no 1 (2021) : 12–20. http://dx.doi.org/10.5005/jp-journals-10028-1423.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
14

McDermott, B., et D. Bell. « NPY and Cardiac Diseases ». Current Topics in Medicinal Chemistry 7, no 17 (1 septembre 2007) : 1692–703. http://dx.doi.org/10.2174/156802607782340939.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
15

Araub, Salman A. « INFLAMMATION AND CARDIAC DISEASES ». Shock 21, no 6 (juin 2004) : 579. http://dx.doi.org/10.1097/00024382-200406000-00015.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
16

Genton, Edward. « Anticoagulation in cardiac diseases ». Postgraduate Medicine 77, no 6 (mai 1985) : 109–16. http://dx.doi.org/10.1080/00325481.1985.11698984.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
17

Tansella, Michele. « Depression and cardiac diseases ». Epidemiologia e Psichiatria Sociale 11, no 2 (juin 2002) : 63–64. http://dx.doi.org/10.1017/s1121189x00005509.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
18

Duhig, Edwina. « Inflammation and Cardiac Diseases ». Pathology 36, no 6 (décembre 2004) : 597. http://dx.doi.org/10.1016/s0031-3025(16)39696-9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
19

Jarvis, Sheba, et Catherine Nelson-Piercy. « Cardiac diseases complicating pregnancy ». Anaesthesia & ; Intensive Care Medicine 11, no 8 (août 2010) : 305–9. http://dx.doi.org/10.1016/j.mpaic.2010.04.015.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
20

Fayssoil, A. « Cardiac diseases in sarcoglycanopathies ». International Journal of Cardiology 144, no 1 (septembre 2010) : 67–68. http://dx.doi.org/10.1016/j.ijcard.2008.12.048.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
21

Dhalla, Naranjan. « Role of Intracellular Ca2+-overload in Cardiac Dysfunction in Heart Disease ». Clinical Cardiology and Cardiovascular Interventions 3, no 2 (2 janvier 2020) : 01–10. http://dx.doi.org/10.31579/2641-0419/038.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
22

Belenkov, Y. N., E. V. Privalova, M. V. Kozhevnikova, E. O. Korobkova, I. S. Ilgisonis, V. Y. Kaplunova, G. A. SHakaryants et al. « Metabolomic Profiling of Patients With Cardiovascular Diseases ». Kardiologiia 17, no 9 (2018) : 59–62. http://dx.doi.org/10.18087/cardio.2018.9.10172.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
23

Christle, Jeffrey W., Steven G. Hershman, Jessica Torres Soto et Euan A. Ashley. « Mobile Health Monitoring of Cardiac Status ». Annual Review of Biomedical Data Science 3, no 1 (20 juillet 2020) : 243–63. http://dx.doi.org/10.1146/annurev-biodatasci-030220-105124.

Texte intégral
Résumé :
Cardiovascular diseases (CVDs) are responsible for more deaths than any other cause, with coronary heart disease and stroke accounting for two-thirds of those deaths. Morbidity and mortality due to CVD are largely preventable, through either primary prevention of disease or secondary prevention of cardiac events. Monitoring cardiac status in healthy and diseased cardiovascular systems has the potential to dramatically reduce cardiac illness and injury. Smart technology in concert with mobile health platforms is creating an environment where timely prevention of and response to cardiac events are becoming a reality.
Styles APA, Harvard, Vancouver, ISO, etc.
24

Bykova, A. A., L. K. Malinovskaya, P. Sh Chomakhidze, O. V. Trushina, Y. R. Shaltaeva, V. V. Belyakov, A. V. Golovin et al. « Exhaled Breath Analysis in Diagnostics of Cardiovascular Diseases ». Kardiologiia 59, no 7 (19 juillet 2019) : 61–67. http://dx.doi.org/10.18087/cardio.2019.7.10263.

Texte intégral
Résumé :
Exhaled breath analysis is a novel tool for diagnostics of different diseases. Taking into account the secretory function of the lungs, the composition of exhaled breath is different in physiological and pathological conditions. In this review we consider of some substances which content vary in cardiovascular diseases – pentane, isoprene, carbon monoxide and trimethylamine. Modern technologies allow to move the analysis of exhaled breath from research laboratories into clinical practice. Thus, a new tool for real time of screening various cardiovascular diseases has appeared in the arsenal of physicians.
Styles APA, Harvard, Vancouver, ISO, etc.
25

Sidorenko, B. A. Sidorenko. « R.G. Oganov, M.N. Mamedov «Handbook of Internal Diseases» ». Kardiologiia 9_2016 (27 septembre 2016) : 67. http://dx.doi.org/10.18565/cardio.2016.9.67.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
26

Debbal, Sidi. « Cardiac Severity Analysis ». Journal of Thoracic Disease and Cardiothoracic Surgery 2, no 2 (11 août 2021) : 01–09. http://dx.doi.org/10.31579/2693-2156/023.

Texte intégral
Résumé :
Phonocardiogram (PCG) signal is a particular approach to explore cardiac activity, to develop technics that may serve medical staff to diagnose several cardiac diseases. We took advantage of PCG signal that shows heart murmurs on its tracing dissimilar to other cardiac signals, to design an algorithm to study and classify heart murmurs. In this paper, the importance is given to the severity of murmurs to highlight its impact, since depending on its stage the patient could be in life-threatening point; therefore, the purpose of this paper is focused on three essential steps: according to the algorithm, extracting murmurs and classifying them to deferent stages then investigate the impact of severity on cardiac frequency through some parameters. The severity stage calculation was based on energy ratio (ER) which is recommended by recent studies as an effective factor, however, we succeed to validate that murmur energy (ME) is also a qualified feature to determine severity. But despite that murmur duration, it's an inefficient way to judge the cardiac severity, which is a very important indicator of the general health of the human body. This study is done on considering many patients and it reveals very interesting results.
Styles APA, Harvard, Vancouver, ISO, etc.
27

Sharma, Vikas, Akhalesh kumar, Kartik Singhal, Chandana Majee et Salahuddin. « Advancement in treating Cardiac Diseases using Cardiac Device ». International Journal of PharmTech Research 13, no 3 (2020) : 217–22. http://dx.doi.org/10.20902/ijptr.2019.130312.

Texte intégral
Résumé :
From the origin of ancient Vedas or Shastras; there was an awareness of artificial intelligence but in different meanings. In present scenario, one has to perform a lot of research for the production of works relating with artificial intelligence. Basically, artificial intelligence is a huge group of skills from advanced machines used for finding the solutions of different fields i.e. in pharma fields or non-pharma fields. The problem of heart failure or heart attack is very big health issue which is assisted with more than 23 million peoples worldwide. Heart failure can be held due to the vasoconstriction or improper pumping mechanism of ventricles. Heart failure heart logic device is a new tsunami in the healthcare system for cardiac devices. This device is in two different forms which are as (ICD) implantable cardioverter defibrillator and other oneiscardiac resynchronization therapy defibrillator (CRT-D). Heart logic heart failure diagnostic device contains multiple sensors to track physiological functioning of the heart. There are Heart sound sensors which checks signs of elevated filling pressure and weakened ventricular contraction. There are also a sensor for checking pulmonary edema. Respiration sensor is used to monitor the rapid shallow breathing system which is associated with shortness of breath. Heart rate sensors check the heart rate and arrhythmia conditions. This device can predict heart failure events weeks before they happen. This artificial intelligence assisted device is showing the sensitivity in more than 70% of peoples to save the valuable lives of the human beings
Styles APA, Harvard, Vancouver, ISO, etc.
28

Cheng, Jianding, Wenzhao Wei, Ying Fang, Nan Zhou, Qiuping Wu et Qianhao Zhao. « Sudden cardiac death and cardiac sodium channel diseases ». Journal of Forensic Science and Medicine 8, no 4 (2022) : 179. http://dx.doi.org/10.4103/jfsm.jfsm_123_22.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
29

Méndez Eirín, Elizabet, Yago Suárez Ouréns et José Luis Guerra Vázquez. « Cardiac manifestations of rheumatic diseases ». Medicina Clínica (English Edition) 156, no 12 (juin 2021) : 615–21. http://dx.doi.org/10.1016/j.medcle.2021.01.006.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
30

Dubois-Deruy, Emilie, Yara El Masri, Annie Turkieh, Philippe Amouyel, Florence Pinet et Jean-Sébastien Annicotte. « Cardiac Acetylation in Metabolic Diseases ». Biomedicines 10, no 8 (29 juillet 2022) : 1834. http://dx.doi.org/10.3390/biomedicines10081834.

Texte intégral
Résumé :
Lysine acetylation is a highly conserved mechanism that affects several biological processes such as cell growth, metabolism, enzymatic activity, subcellular localization of proteins, gene transcription or chromatin structure. This post-translational modification, mainly regulated by lysine acetyltransferase (KAT) and lysine deacetylase (KDAC) enzymes, can occur on histone or non-histone proteins. Several studies have demonstrated that dysregulated acetylation is involved in cardiac dysfunction, associated with metabolic disorder or heart failure. Since the prevalence of obesity, type 2 diabetes or heart failure rises and represents a major cause of cardiovascular morbidity and mortality worldwide, cardiac acetylation may constitute a crucial pathway that could contribute to disease development. In this review, we summarize the mechanisms involved in the regulation of cardiac acetylation and its roles in physiological conditions. In addition, we highlight the effects of cardiac acetylation in physiopathology, with a focus on obesity, type 2 diabetes and heart failure. This review sheds light on the major role of acetylation in cardiovascular diseases and emphasizes KATs and KDACs as potential therapeutic targets for heart failure.
Styles APA, Harvard, Vancouver, ISO, etc.
31

Juhola, Martti, Henry Joutsijoki, Kirsi Penttinen, Disheet Shah, Risto-Pekka Pölönen et Katriina Aalto-Setälä. « Data analytics for cardiac diseases ». Computers in Biology and Medicine 142 (mars 2022) : 105218. http://dx.doi.org/10.1016/j.compbiomed.2022.105218.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
32

TOUMANIDIS, S. T., C. M. PAPAMICHAEL, L. G. ANTONIADES, M. I. PANTELIA, N. S. SARIDAKIS, M. E. MAVRIKAKIS, D. A. SIDERIS et S. D. MOULOPOULOS. « Cardiac involvement in collagen diseases ». European Heart Journal 16, no 2 (février 1995) : 257–62. http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a060893.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
33

Schannwell, C. M., et B. E. Strauer. « Cardiac diseases of the elderly ». DMW - Deutsche Medizinische Wochenschrift 130, no 12 (mars 2005) : 693–97. http://dx.doi.org/10.1055/s-2005-865081.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
34

Komar, Monika. « Cardiac Tumours and Malignancy Diseases ». Journal of Rare Cardiovascular Diseases 3, no 6 (2018) : 191. http://dx.doi.org/10.20418/jrcd.vol3no6.323.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
35

AMAUCHI, HIROSHI. « Cineangiographic Technique in Cardiac Diseases ». Japanese Journal of Radiological Technology 53, no 6 (1997) : 708–13. http://dx.doi.org/10.6009/jjrt.kj00001355783.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
36

Gawałko, Monika, Paweł Balsam, Piotr Lodziński, Marcin Grabowski, Bartosz Krzowski, Grzegorz Opolski et Jędrzej Kosiuk. « Cardiac Arrhythmias in Autoimmune Diseases ». Circulation Journal 84, no 5 (24 avril 2020) : 685–94. http://dx.doi.org/10.1253/circj.cj-19-0705.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
37

Nunes, Maria Carmo P., Milton Henriques Guimarães Júnior, Adriana Costa Diamantino, Claudio Leo Gelape et Teresa Cristina Abreu Ferrari. « Cardiac manifestations of parasitic diseases ». Heart 103, no 9 (11 mars 2017) : 651–58. http://dx.doi.org/10.1136/heartjnl-2016-309870.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
38

Anan, Ryuichiro, Masanori Nakagawa, Masaaki Miyata, Itsuro Higuchi, Shoichiro Nakao, Masahito Suehara, Mitsuhiro Osame et Hiromitsu Tanaka. « Cardiac Involvement in Mitochondrial Diseases ». Circulation 91, no 4 (15 février 1995) : 955–61. http://dx.doi.org/10.1161/01.cir.91.4.955.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
39

Pourmand, Rahman. « CARDIAC DYSFUNCTION IN NEUROMUSCULAR DISEASES ». Neurologist 6, no 2 (mars 2000) : 67–82. http://dx.doi.org/10.1097/00127893-200006020-00001.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
40

Maksimović, R., P. M. Seferović, A. D. Ristić, B. Vujisić-Tešić, D. S. Simeunović, G. Radovanović, M. Matucci-Cerinic et B. Maisch. « Cardiac imaging in rheumatic diseases ». Rheumatology 45, suppl_4 (octobre 2006) : iv26—iv31. http://dx.doi.org/10.1093/rheumatology/kel309.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
41

Kuliev, Anver, Ekaterina Pomerantseva, Dana Polling, Oleg Verlinsky et Svetlana Rechitsky. « PGD for inherited cardiac diseases ». Reproductive BioMedicine Online 24, no 4 (avril 2012) : 443–53. http://dx.doi.org/10.1016/j.rbmo.2011.12.009.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
42

Allen, Hugh D., Philip T. Thrush, Timothy M. Hoffman, Kevin M. Flanigan et Jerry R. Mendell. « Cardiac Management in Neuromuscular Diseases ». Physical Medicine and Rehabilitation Clinics of North America 23, no 4 (novembre 2012) : 855–68. http://dx.doi.org/10.1016/j.pmr.2012.08.001.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
43

Shimizu, Ippei, et Tohru Minamino. « Cellular senescence in cardiac diseases ». Journal of Cardiology 74, no 4 (octobre 2019) : 313–19. http://dx.doi.org/10.1016/j.jjcc.2019.05.002.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
44

Daniels, Curt J., et Wayne H. Franklin. « COMMON CARDIAC DISEASES IN ADOLESCENTS ». Pediatric Clinics of North America 44, no 6 (décembre 1997) : 1591–601. http://dx.doi.org/10.1016/s0031-3955(05)70576-9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
45

Harris, Samantha P., et Pieter P. de Tombe. « Sarcomeric mutations in cardiac diseases ». Pflügers Archiv - European Journal of Physiology 471, no 5 (11 avril 2019) : 659–60. http://dx.doi.org/10.1007/s00424-019-02275-2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
46

Panteghini, Mauro. « Biochemical markers of cardiac diseases ». Jugoslovenska medicinska biohemija 23, no 3 (2004) : 201–11. http://dx.doi.org/10.2298/jmh0403201p.

Texte intégral
Résumé :
This article reviews the current contribution of the determination of biochemical markers to clinical cardiology and discusses some important developments in this field. Biochemical markers play a pivotal role in the diagnosis and management of patients with acute coronary syndrome (ACS), as witnessed by the incorporation of cardiac troponins into new international guidelines for patients with ACS and in the redefinition of myocardial infarction. Despite the success of cardiac troponins, there is still a need for development of early markers that can reliably rule out ACS from the emergency room at presentation and detect myocardial ischemia also in the absence of irreversible myocyte injury. Under investigation are two classes of indicators: markers of early injury/ischemia and markers of coronary plaque instability and disruption. Finally, with the characterization of the cardiac natriuretic peptides, Laboratory Medicine is also assuming part in the assessment of cardiac function.
Styles APA, Harvard, Vancouver, ISO, etc.
47

Uzun Ozsahin, Dilber, Cemre Ozgocmen, Ozlem Balcioglu, Ilker Ozsahin et Berna Uzun. « Diagnostic AI and Cardiac Diseases ». Diagnostics 12, no 12 (22 novembre 2022) : 2901. http://dx.doi.org/10.3390/diagnostics12122901.

Texte intégral
Résumé :
(1) Background: The purpose of this study is to review and highlight recent advances in diagnostic uses of artificial intelligence (AI) for cardiac diseases, in order to emphasize expected benefits to both patients and healthcare specialists; (2) Methods: We focused on four key search terms (Cardiac Disease, diagnosis, artificial intelligence, machine learning) across three different databases (Pubmed, European Heart Journal, Science Direct) between 2017–2022 in order to reach relatively more recent developments in the field. Our review was structured in order to clearly differentiate publications according to the disease they aim to diagnose (coronary artery disease, electrophysiological and structural heart diseases); (3) Results: Each study had different levels of success, where declared sensitivity, specificity, precision, accuracy, area under curve and F1 scores were reported for every article reviewed; (4) Conclusions: the number and quality of AI-assisted cardiac disease diagnosis publications will continue to increase through each year. We believe AI-based diagnosis should only be viewed as an additional tool assisting doctors’ own judgement, where the end goal is to provide better quality of healthcare and to make getting medical help more affordable and more accessible, for everyone, everywhere.
Styles APA, Harvard, Vancouver, ISO, etc.
48

Mateen, Farrah J., Diederik van de Beek, Walter K. Kremers, Richard C. Daly, Brooks S. Edwards, Christopher G. A. McGregor et Eelco F. M. Wijdicks. « Neuromuscular Diseases After Cardiac Transplantation ». Journal of Heart and Lung Transplantation 28, no 3 (mars 2009) : 226–30. http://dx.doi.org/10.1016/j.healun.2008.12.004.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
49

Tseliou, E. « Cell therapy for cardiac diseases ». Continuing Cardiology Education 3, no 4 (décembre 2017) : 170–75. http://dx.doi.org/10.1002/cce2.69.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
50

Li, WilliamA, et Yuchuan Ding. « Cardiac preconditioning and cardiovascular diseases ». Heart and Mind 1, no 1 (2017) : 17. http://dx.doi.org/10.4103/hm.hm_4_17.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Vous pouvez également être intéressé par les bibliographies sur le sujet « Cardiae diseases » pour d’autres types de sources :
Thèses Livres
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie